Screener
Chemours CC Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 15.3%-2.9pp | 15.1%-3.8pp | 15.5%-4.2pp | 17.3%-2.2pp | 18.2%-1.2pp | |
| Net margin | -5.2%+2.1pp | -7%-7.3pp | -6.6%-7.9pp | -6%-7.1pp | -7.3%-9.2pp | |
| Returns | ||||||
| Return on invested capital | 5.8%+6.1pp | -0.6%-4.1pp | -0.2%-6.2pp | 1.4%-5.5pp | -0.3%-8.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.7×0.0× | 1.8×+0.1× | 1.8×+0.1× | 1.7×0.0× | 1.7×-0.2× | |
| Leverage | ||||||
| Net debt / EBITDA | 6.4×-6.1× | 12.7×+6.3× | 11.3×+5.8× | 9.8×+3.5× | 12.5×+6.6× | |
| Valuation | ||||||
| Market capitalization | $2.27B+26.6% | $3.31B+63.6% | $1.77B-30.0% | $2.37B-21.9% | $1.67B-50.4% | |
| Price / sales | 0.4×+0.1× | 0.6×+0.2× | 0.3×-0.1× | 0.4×-0.1× | 0.3×-0.3× | |
| EV / EBITDA | 10.7×-7.6× | 23.6×+13.8× | 16.7×+7.3× | 15.8×+4.4× | 17.8×+6.6× | |
| Dividend yield | 2.4%-4.5pp | 1.6%-5.7pp | 4.4%-1.4pp | 4.2%-0.7pp | 7.4%+3.0pp |
FAQ
- Where do Chemours's ratios come from?
- Every ratio is computed from Chemours's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
